Miller Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Miller Investment Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.9M	Sell	133,938 -18,998	-12%	-$2.02M	1.38%	16
2025 Q4	$15.8M	Sell	152,936 -28,982	-16%	-$2.82M	1.54%	16
2025 Q3	$16.4M	Buy	181,918 +382	+0.2%	+$33.5K	1.65%	15
2025 Q2	$16M	Sell	181,536 -8,098	-4%	-$702K	1.68%	15
2025 Q1	$17.3M	Sell	189,634 -380	-0.2%	-$34.2K	1.91%	12
2024 Q4	$16.4M	Sell	190,014 -17,521	-8%	-$1.58M	1.79%	13
2024 Q3	$19.7M	Buy	207,535 +24,446	+13%	+$2.32M	2.05%	10
2024 Q2	$16.7M	Buy	183,089 +39,044	+27%	+$3.49M	2%	14
2024 Q1	$13.1M	Buy	144,045 +1,036	+0.7%	+$90.7K	1.67%	19
2023 Q4	$11.6M	Sell	143,009 -1,410	-1%	-$111K	1.66%	20
2023 Q3	$11.5M	Sell	144,419 -564	-0.4%	-$45.5K	1.82%	16
2023 Q2	$11.4M	Buy	144,983 +141,793	+4,445%	+$11.1M	1.74%	17
2023 Q1	$248K	Buy	3,190 +267	+9%	+$20.6K	0.04%	87
2022 Q4	$227K	Buy	+2,923	New	+$216K	0.04%	89

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Miller Investment Management's PPH Position: Q1 2026 in Review

Miller Investment Management reduced its VanEck Pharmaceutical ETF (PPH) stake by 12% in Q1 2026, selling an estimated $2.02M and leaving 133,938 shares worth $13.9M. The position accounts for 1.38% of the portfolio, ranked #16.

Miller Investment Management first reported a position in PPH in Q4 2022 and has held it in 14 quarters since. The position peaked at $19.7M in Q3 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

Miller Investment Management held 133,938 shares of VanEck Pharmaceutical ETF worth $13.9M as of Q1 2026.
Miller Investment Management sold 18,998 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $2.02M.
VanEck Pharmaceutical ETF made up 1.38% of Miller Investment Management's portfolio in Q1 2026, its #16 holding.
Miller Investment Management first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 14 quarters since.
Miller Investment Management's VanEck Pharmaceutical ETF position peaked at $19.7M in Q3 2024.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Miller Investment Management's 13F filing for Q1 2026, filed 8 May 2026.